These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2537141)

  • 1. Novobiocin- and phorbol-12-myristate-13-acetate-induced differentiation of human leukemia cells associated with a reduction in topoisomerase II activity.
    Constantinou A; Henning-Chubb C; Huberman E
    Cancer Res; 1989 Mar; 49(5):1110-7. PubMed ID: 2537141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.
    Zwelling LA; Chan D; Hinds M; Mayes J; Silberman LE; Blick M
    Cancer Res; 1988 Dec; 48(23):6625-33. PubMed ID: 2846155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commitment to erythroid differentiation in mouse erythroleukemia cells is controlled by alterations in topoisomerase II alpha phosphorylation.
    Constantinou AI; Vaughan AT; Yamasaki H; Kamath N
    Cancer Res; 1996 Sep; 56(18):4192-9. PubMed ID: 8797591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase II alpha promoter trans-activation early in monocytic differentiation of HL-60 human leukemia cells.
    Fraser DJ; Brandt TL; Kroll DJ
    Mol Pharmacol; 1995 Apr; 47(4):696-706. PubMed ID: 7723730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C beta gene expression is associated with susceptibility of human promyelocytic leukemia cells to phorbol ester-induced differentiation.
    Tonetti DA; Horio M; Collart FR; Huberman E
    Cell Growth Differ; 1992 Oct; 3(10):739-45. PubMed ID: 1445803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific protein phosphorylation in human promyelocytic HL-60 leukemia cells susceptible or resistant to induction of cell differentiation by phorbol-12-myristate-13-acetate.
    Anderson NL; Gemmell MA; Coussens PM; Murao S; Huberman E
    Cancer Res; 1985 Oct; 45(10):4955-62. PubMed ID: 3861240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid and phorbol ester induced hyperphosphorylation of topoisomerase II-alpha is an early event in HL-60 human leukaemia cell differentiation: effect on topoisomerase activity and etoposide sensitivity.
    Chresta CM; Hall BF; Francis GE
    Leukemia; 1995 Aug; 9(8):1373-81. PubMed ID: 7643627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.
    Harker WG; Slade DL; Parr RL; Feldhoff PW; Sullivan DM; Holguin MH
    Cancer Res; 1995 Apr; 55(8):1707-16. PubMed ID: 7712479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phorbol myristate acetate inhibits phosphoinositol lipid-specific phospholipase C activity via protein kinase C activation in conditions inducing differentiation in HL-60 cells.
    Cost H; Barreau P; Basset M; Le Peuch C; Geny B
    Cell Biochem Funct; 1991 Oct; 9(4):263-73. PubMed ID: 1807858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
    Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism for transcriptional activation of ganglioside GM3 synthase and its function in differentiation of HL-60 cells.
    Chung TW; Choi HJ; Lee YC; Kim CH
    Glycobiology; 2005 Mar; 15(3):233-44. PubMed ID: 15385432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase C activities with different characteristics, including substrate specificity, from two human HL-60 leukemia cell variants.
    Homma Y; Gemmell MA; Huberman E
    Cancer Res; 1988 May; 48(10):2744-8. PubMed ID: 3162823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to etoposide in human leukemia HL-60 cells: reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides.
    Ganapathi R; Constantinou A; Kamath N; Dubyak G; Grabowski D; Krivacic K
    Mol Pharmacol; 1996 Aug; 50(2):243-8. PubMed ID: 8700130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of the differentiation of WEHI-3B D+ monomyelocytic leukemia cells by inhibitors of topoisomerase II.
    Rappa G; Lorico A; Sartorelli AC
    Cancer Res; 1990 Oct; 50(20):6723-30. PubMed ID: 2170008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiation.
    Zwelling LA; Hinds M; Chan D; Altschuler E; Mayes J; Zipf TF
    Cancer Res; 1990 Nov; 50(22):7116-22. PubMed ID: 2171756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypophosphorylation of topoisomerase II in etoposide (VP-16)-resistant human leukemia K562 cells associated with reduced levels of beta II protein kinase C.
    Ritke MK; Murray NR; Allan WP; Fields AP; Yalowich JC
    Mol Pharmacol; 1995 Nov; 48(5):798-805. PubMed ID: 7476909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of a potentially phorbol-regulatable region of the human topoisomerase II alpha gene promoter.
    Loflin PT; Hochhauser D; Hickson ID; Morales F; Zwelling LA
    Biochem Biophys Res Commun; 1994 Apr; 200(1):489-96. PubMed ID: 8166723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered phosphorylation, biosynthesis and degradation of the 170 kDa isoform of topoisomerase II in amsacrine-resistant human leukemia cells.
    Ganapathi R; Zwelling L; Constantinou A; Ford J; Grabowski D
    Biochem Biophys Res Commun; 1993 May; 192(3):1274-80. PubMed ID: 8389546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phorbol ester induces apoptosis in HL-60 promyelocytic leukemia cells but not in HL-60 PET mutant.
    Macfarlane DE; O'Donnell PS
    Leukemia; 1993 Nov; 7(11):1846-51. PubMed ID: 8231252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. dsDNA-stimulated phosphorylation of a 72-kDa nucleoprotein accompanies PMA-induced HL-60 leukemic cell differentiation.
    Konno S; Wu JM
    Biochem Int; 1991 Jul; 24(5):877-88. PubMed ID: 1776955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.